Gilead agrees to $45 million Texas Medicaid kickback settlement
Gilead Sciences agreed to pay $45 million to settle allegations pursued by Texas authorities that its marketing practices improperly influenced prescriptions reimbursed by the Texas Medicaid program. The claims, also brought by a whistleblower, alleged that…
